scispace - formally typeset
M

Masataka Mochizuki

Researcher at University of Tokyo

Publications -  9
Citations -  344

Masataka Mochizuki is an academic researcher from University of Tokyo. The author has contributed to research in topics: Reverse transcriptase & Hepatitis C virus. The author has an hindex of 4, co-authored 9 publications receiving 305 citations. Previous affiliations of Masataka Mochizuki include University of Shizuoka & National Taiwan University.

Papers
More filters
Journal ArticleDOI

Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives.

TL;DR: The amino acid-type fullerene derivative was the most efficient in human immunodeficiency virus-reverse transcriptase inhibition of hepatitis C virus RNA-dependent RNA polymerase inhibition.
Journal ArticleDOI

Antibacterial and antiproliferative activity of cationic fullerene derivatives.

TL;DR: The fullerene derivatives with a long alkyl chain did not show antibacterial activity, and the alkylated C(60)-bis(N,N-dimethylpyrrolidinium iodide derivatives inhibited bacteria and cancer cell growth effectively.
Journal ArticleDOI

Inhibitory effect of fullerene derivatives on glutathione reductase

TL;DR: Fullerene derivatives which have carboxylic acid moiety effectively inhibited glutathione reductase activity and enhanced the inhibition activity at 37°C.
Journal ArticleDOI

Human Immunodeficiency Virus-Reverse Transcriptase Inhibition and Hepatitis C Virus RNA-Dependent RNA Polymerase Inhibition Activities of Fullerene Derivatives.

TL;DR: In this article, the authors examined the human immunodeficiency virus-reverse transcriptase and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of cationic, anionic, and amino acid-type fullerene derivatives.
Journal ArticleDOI

Synthesis of water-soluble C60-porphyrin hybrid compounds.

TL;DR: Water-soluble C60-porphyrin hybrid molecules were first synthesized toward their pharmaceutical applications and later developed into C60/C60 hybrid molecules for drug discovery and development.